Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.84)
# 3,534
Out of 5,172 analysts
181
Total ratings
21.76%
Success rate
-10.93%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $0.93 | +871.92% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.47 | +13,505.44% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.97 | +282.29% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.22 | +227.87% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.06 | +9,608.74% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.85 | +927.03% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $7.35 | +185.71% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $0.78 | +1,815.95% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.16 | +25,825.93% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $2.04 | +5,782.35% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.48 | +517.28% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $7.97 | +1,029.23% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $9.62 | +97.51% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.88 | +455.56% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.94 | +538.30% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.77 | +12,876.90% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $3.17 | +1,703,370.03% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.61 | +666.28% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.45 | +456,421.74% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $8.50 | +5,782.35% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $36.00 | +566.67% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.08 | +7,307.41% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $14.30 | +55,844.06% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.46 | +379.45% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.81 | +1,557.46% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.00 | +900.00% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.44 | +423.26% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.75 | +81.82% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $61.70 | -61.10% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.60 | +569,900.00% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.88 | +2,161,447.21% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $0.93
Upside: +871.92%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.47
Upside: +13,505.44%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.97
Upside: +282.29%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.22
Upside: +227.87%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.06
Upside: +9,608.74%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.85
Upside: +927.03%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $7.35
Upside: +185.71%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.78
Upside: +1,815.95%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.16
Upside: +25,825.93%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $2.04
Upside: +5,782.35%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.48
Upside: +517.28%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $7.97
Upside: +1,029.23%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $9.62
Upside: +97.51%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.88
Upside: +455.56%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.94
Upside: +538.30%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.77
Upside: +12,876.90%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $3.17
Upside: +1,703,370.03%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.61
Upside: +666.28%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.45
Upside: +456,421.74%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $8.50
Upside: +5,782.35%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $36.00
Upside: +566.67%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.08
Upside: +7,307.41%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $14.30
Upside: +55,844.06%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.46
Upside: +379.45%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.81
Upside: +1,557.46%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.00
Upside: +900.00%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $3.44
Upside: +423.26%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.75
Upside: +81.82%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $61.70
Upside: -61.10%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.60
Upside: +569,900.00%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.88
Upside: +2,161,447.21%